LRRC7
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| leucine rich repeat containing 7 | MIM:614453 | Ensembl:ENSG00000033122 | HGNC:HGNC:18531 | PA134879588 | 1p31.1 |
GO terms in LRRC7
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IPI | GO:0005515 | protein binding |
| MF | IBA | GO:0035255 | ionotropic glutamate receptor binding |
| BP | IBA | GO:0007268 | chemical synaptic transmission |
| BP | IBA | GO:0010976 | positive regulation of neuron projection development |
| BP | IBA | GO:0043113 | receptor clustering |
| BP | TAS | GO:0043312 | neutrophil degranulation |
| BP | IBA | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity |
| BP | IBA | GO:0097120 | receptor localization to synapse |
| BP | IBA | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane |
| BP | IBA | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome |
| CC | TAS | GO:0005576 | extracellular region |
| CC | IBA | GO:0005911 | cell-cell junction |
| CC | IBA | GO:0005913 | cell-cell adherens junction |
| CC | IBA | GO:0008328 | ionotropic glutamate receptor complex |
| CC | IBA | GO:0014069 | postsynaptic density |
| CC | IEA | GO:0014069 | postsynaptic density |
| CC | IBA | GO:0016323 | basolateral plasma membrane |
| CC | IBA | GO:0030054 | cell junction |
| CC | IEA | GO:0030054 | cell junction |
| CC | TAS | GO:0035580 | specific granule lumen |
| CC | IBA | GO:0043005 | neuron projection |
| CC | IBA | GO:0043194 | axon initial segment |
| CC | IBA | GO:0045202 | synapse |
| CC | IBA | GO:0045211 | postsynaptic membrane |
| CC | IEA | GO:0045211 | postsynaptic membrane |
| CC | IBA | GO:0097060 | synaptic membrane |
Gene expression in normal tissue: LRRC7
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LRRC7
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-168249 | Innate Immune System |
| reactome | R-HSA-168256 | Immune System |
| reactome | R-HSA-6798695 | Neutrophil degranulation |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD524 | ISX-9 | 3 |
| iGMDRD23 | Gossypol | 7 |
| iGMDRD598 | QS-11 | 1 |
| iGMDRD60 | Quinoclamine | 4 |
| iGMDRD64 | Parbendazole | 2 |
| iGMDRD369 | TGX-115 | 3 |
| iGMDRD562 | Navitoclax | 9 |
| iGMDRD577 | BIX01294 | 4 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
| iGMDRD441 | TW 37 | 1 |
| iGMDRD782 | DC-45-A2 | 6 |
| iGMDRD207 | Capsaicin | 1 |
| iGMDRD255 | SB225002 | 7 |
| iGMDRD138 | PX 12 | 2 |
| iGMDRD679 | Bistramide A | 2 |
| iGMDRD466 | Chaetocin | 3 |
| iGMDRD394 | BX-795 | 3 |
| iGMDRD193 | Fqi1 | 1 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD781 | Sirolimus | 7 |
| iGMDRD427 | ABT737 | 7 |
| iGMDRD779 | PRL-3 Inhibitor I | 6 |
| iGMDRD1008 | SR-II-138A | 2 |
| iGMDRD772 | BRD4770 | 6 |
| iGMDRD889 | Compound 7d-cis | 4 |
| iGMDRD387 | CHIR-99021 | 1 |
| iGMDRD433 | Lexibulin | 2 |
| iGMDRD151 | CHM-1 | 3 |
| iGMDRD126 | Tipifarnib | 3 |
| iGMDRD322 | FK 866 | 3 |
| iGMDRD82 | Quiflapon | 3 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD300 | Tozasertib | 2 |
| iGMDRD505 | Pevonedistat | 2 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD872 | BRD7137 | 4 |
| iGMDRD882 | CIL41 | 2 |
| iGMDRD286 | Nsc 632839 | 7 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD77 | Itraconazole | 3 |
| iGMDRD267 | Oligomycin A | 3 |
| iGMDRD289 | Parthenolide | 3 |
| iGMDRD105 | Triptolide | 1 |
| iGMDRD121 | GMX1778 | 4 |
| iGMDRD158 | NSC141540 | 3 |
| iGMDRD103 | SN-38 | 2 |
| iGMDRD132 | (-)-gallocatechin-3-O-gallate | 3 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD177 | Teniposide | 3 |
| iGMDRD901 | ELCPK | 1 |
| iGMDRD698 | Neratinib | 2 |
| iGMDRD341 | Triacsin c | 2 |
| iGMDRD522 | ML-030 | 2 |
| iGMDRD299 | ICL 670 | 2 |
| iGMDRD150 | RITA | 3 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD607 | Ubistatin B | 1 |
| iGMDRD84 | Lovastatin acid | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in LRRC7

